Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.27435/fullpdf
Reference30 articles.
1. Human idiopathic membranous nephropathy: a mystery solved?;Glassock;N Engl J Med,2009
2. B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses;Mouquet;J Invest Dermatol,2008
3. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders;Masaki;Ann Rheum Dis,2009
4. IgG4-related sclerosing disease;Kamisawa;Intern Med,2006
5. IgG4-related sclerosing disease;Kamisawa;World J Gastroenterol,2008
Cited by 467 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of rituximab induction therapy and effect of rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis;European Journal of Internal Medicine;2024-09
2. Case report: Isolated immunoglobulin G4-related sclerosing cholangitis misdiagnosed as hilar cholangiocarcinoma;Frontiers in Oncology;2024-05-23
3. Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin;JCI Insight;2024-05-07
4. IgG4-related autoimmune pancreatitis and sclerosing cholangitis: A case report and literature review;Medicine;2024-04-26
5. Unraveling the complexities of IgG4-related disease: Musings from a histopathologist;Seminars in Diagnostic Pathology;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3